← Back to Clinical Trials
Recruiting NCT06569901

NCT06569901 Strengthening Hope After ICU Discharge

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06569901
Status Recruiting
Phase
Sponsor Oslo University Hospital
Condition Critical Care
Study Type INTERVENTIONAL
Enrollment 75 participants
Start Date 2024-09-10
Primary Completion 2025-12

Trial Parameters

Condition Critical Care
Sponsor Oslo University Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 75
Sex ALL
Min Age 18 Years
Max Age 85 Years
Start Date 2024-09-10
Completion 2025-12
Interventions
Hope Intervention

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to evaluate an interventional program that aims to strengthen hope in intensive care unit (ICU) patients in the rehabilitation phase. The main questions it aims to answer are: To develop and implement a follow-up service to strengthen hope in ICU patients, and to evaluate the effect on hope in a stepped wedge randomized trial. To identify possible predictive factors (facilitators and barriers) associated with hope. Participants will be asked to take part in an ICU follow-up service, a "Hope Intervention" consisting of digital individual- and group conversations. The program will address topics that are important for hope, such as active involvement, social relationships, believes and thoughts of the future. We will compare the level of hope between participants who have completed the "Hope Intervention" to those that have not yet completed the program.

Eligibility Criteria

Inclusion Criteria: * Patients ≥18 years * ICU patient for \> 48 hours * must be able to communicate verbally just after their ICU stay and be able to handle digital meetings Exclusion Criteria: * Patients with severe cognitive impairment * Do not understand and speak Norwegian * Patients with major psychiatric challenges, suicidal attempts as a reason for ICU stay * Age over 85 years.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology